+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Formation of DNA adducts by ellipticine and its micellar form in rats - a comparative study



Formation of DNA adducts by ellipticine and its micellar form in rats - a comparative study



Sensors 14(12): 22982-22997



The requirements for early diagnostics as well as effective treatment of cancer diseases have increased the pressure on development of efficient methods for targeted drug delivery as well as imaging of the treatment success. One of the most recent approaches covering the drug delivery aspects is benefitting from the unique properties of nanomaterials. Ellipticine and its derivatives are efficient anticancer compounds that function through multiple mechanisms. Formation of covalent DNA adducts after ellipticine enzymatic activation is one of the most important mechanisms of its pharmacological action. In this study, we investigated whether ellipticine might be released from its micellar (encapsulated) form to generate covalent adducts analogous to those formed by free ellipticine. The (32)P-postlabeling technique was used as a useful imaging method to detect and quantify covalent ellipticine-derived DNA adducts. We compared the efficiencies of free ellipticine and its micellar form (the poly(ethylene oxide)-block-poly(allyl glycidyl ether) (PAGE-PEO) block copolymer, P 119 nanoparticles) to form ellipticine-DNA adducts in rats in vivo. Here, we demonstrate for the first time that treatment of rats with ellipticine in micelles resulted in formation of ellipticine-derived DNA adducts in vivo and suggest that a gradual release of ellipticine from its micellar form might produce the enhanced permeation and retention effect of this ellipticine-micellar delivery system.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057894193

Download citation: RISBibTeXText

PMID: 25479328

DOI: 10.3390/s141222982


Related references

Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitro. Neuro Endocrinology Letters 36 Suppl 1(): 22-28, 2016

Formation and persistence of DNA adducts of anticancer drug ellipticine in rats. Toxicology 236(1-2): 50-60, 2007

Ellipticine forms covalent DNA adducts in rats with properties similar to adducts formed in vitro after its activation by cytochromosomes P450 or peroxidases. Proceedings of the American Association for Cancer Research Annual Meeting 42: 252, March, 2001

DNA adducts are formed from ellipticine and ellipticine-human serum albumin in cells transfected with cytochrome P450. Proceedings of the American Association for Cancer Research Annual Meeting (41): 765, March, 2000

The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide. Cancer Research 64(22): 8374-8380, 2004

Interactions between ellipticine and phospho lipids effect of ellipticine and 9 methoxy ellipticine on the phase behavior of phosphatidyl glycerols a mono layer study. European Journal of Biochemistry 105(3): 593-602, 1980

Formation and repair of benzo a pyrene dna adducts in young and aging rats and identification of adducts. Proceedings of the American Association for Cancer Research Annual Meeting 31: 97, 1990

Microsomal activation of 4-hydroxy-tamoxifen to form DNA adducts Comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 150, 1995

Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen. Carcinogenesis 16(1): 11-15, 1995

Uterine peroxidase activation of tamoxifen metabolites to form DNA adducts Comparison with the adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 119, 1996

Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen. Carcinogenesis 17(9): 1785-1790, 1996

Comparative study of multi walled carbon nanotubes-based electrodes in micellar media and their application to micellar electrokinetic capillary chromatography. Talanta 74(3): 376-386, 2008

Early formation of DNA adducts compared with tumor formation in a long-term tumor study in rats after administration of 2-nitrofluorene. Carcinogenesis 16(9): 2135-2141, 1995

DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling. International Journal of Cancer 107(6): 885-890, 2003

Microbial transformations of natural anti tumor agents 8. formation of 8 hydroxy ellipticine and 9 hydroxy ellipticine. Drug Metabolism and Disposition 7(4): 211-214, 1979